Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $6 on, Mar 29th, 2023
Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $6 on, Mar 29th, 2023.
Gil has made no other calls on TSHA in the last 4 months.
There are 9 other peers that have a rating on TSHA. Out of the 9 peers that are also analyzing TSHA, 3 agree with Gil's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yun Zhong of "BTIG" Downgraded from Strong Buy to Hold on, Thursday, February 2nd, 2023
- Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $1.5 on, Wednesday, February 1st, 2023
- Michael Ulz of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $3 on, Friday, January 27th, 2023
These are the ratings of the 6 analyists that currently disagree with Gil
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $4 on, Wednesday, February 1st, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $13 on, Wednesday, February 1st, 2023
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, February 1st, 2023
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $6 on, Wednesday, February 1st, 2023
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy with Decreased Target to $13 on, Wednesday, February 1st, 2023
- Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $10 on, Wednesday, January 4th, 2023
